Abstract
In this study, we examined the cutaneous effects of tacalcitol [1, 24(R)(OH)2D3] on epidermal proliferation, differentiation, and skin inflammation in vivo using hairless mice. Tacalcitol was shown to inhibit epidermal proliferation using TPA-induced ornithine decarboxylase activity and DNA synthesis as indices, and the induction of epidermal differentiation using type I transglutaminase activity as an index. Tacalcitol also displayed an antiinflammatory effect on TPA-induced inflammatory changes histopathologically. These results confirm the clinical efficacy of tacalcitol in psoriasis, and suggest that it may be efficacious in the treatment of other inflammatory skin diseases.
Similar content being viewed by others
References
Astrup EG, Iversen OH (1981) Cell population kinetics in hairless mouse epidermis following a single topical application of 12-O-tetradecanoylphorbol-13-acetate., Carcinogenesis 2 (10):999–1006
Burton K (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Biochem J 62:315–323
Burton K (1968) Determination of DNA concentration with diphenylamine. Methods Enzymol 12:163–166
Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847–7851
Chida K, Hashiba H, Suda T, Kuroki T (1984) Inhibition by 1α,25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate and teleocidin B. Cancer Res 44:1387–1391
Clemens TL, Garrett PK, Zhou XY, Pike JW, Haussler RM, Dempster WD (1988) Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology 122:1224–1230
Connerty HV, Briggs AR (1966) Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 45(3):290–296
Connor MJ, Lowe NJ (1983) Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids. Cancer Res 43:5174–5177
Cooper KD, Baadsgaard O, Elder JT, Sauder DN, Voorhees JJ, Fisher GJ (1988) Increased levels of an interleukin-1 inhibitor block interleukin-1 activity but not immunoreactivity or mRNA expression of interleukin-1 beta in psoriasis skin. J Invest Dermatol 90:552
Esmann J, Cooper KD, Voorhees JJ, Fisher GJ (1988) Membrane associated transglutaminase activity is increased in psoriatic involved versus normal epidermis. J Invest Dermatol 90:556
George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM (1990) Regulation of transglutaminase type II by transforming growth factor-β1 in normal and transformed human epidermal keratinocyte. J Biol Chem 265(19):11098–11104
Gerritsen MJP, Boezeman JBM, Van Vlijmen-Willems IMJJ, Van De Kerkhof PCM (1994) The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 131:57–63
Gupta AK, Fisher GJ, Elder JT, Nickoloff BJ, Voorhees JJ (1988) Spningosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity and activation of protein kinase C in mouse skin. J Invest Dermatol 91:486–491
Gupta AK, Fisher GJ, Elder JT, Talwar HS, Esmann J, Duell EA, Nickoloff BJ, Voorhees JJ (1989) Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis. J Invest Dermatol 93:379–386
Hammarstrom S, Lindgren JA, Marcel C, Duell EA, Anderson TF, Voorhees JJ (1975) Increased concentration of non-esterified arachidonic acid. 12L-hydroxy-5,8,10,14-eicostetraenoic acid, prostaglandin E2 and prostaglandin F2a in the epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130–5134
Holick M, Smith E, Pincus S (1987) Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Arch Dermatol 123:1677a-1683a
Horn F, Marks F, Fisher GJ, Marcelo CLK, Voorhees JJ (1987) Decreased protein kinase C activity in psoriatic versus normal epidermis. J Invest Dermatol 88:220–222
Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology 113:1950–1957
Inoue H, Tanioka H, Shiba K, Asada A, Kato Y, Takeda Y (1974) Effect of isoproterenol on polyamine metabolism in mouse salivary glands. J Biochem 75:679–687
Ishida H, Norman AW (1988) Demonstration of high affinity receptor for 1,25(OH)2D3 in rat pancreas. Mol Cell Endocrinol 60:109–117
Janne J, Raina A, Siimes M (1968) Stimulation of polyamine synthesis by growth hormone in rat liver. Biochim Biophys Acta 166:419–426
Kato T, Tadaki T, Terui T, Tagami H (1989) Treatment of psoriasis by synthetic bioactive vitamin D3, 1α,24-hydroxycholecalciferol ointment. Acta Dermatol 84:43–436
Kay JE, Lindsay VJ (1973) Polyamine synthesis during lymphocyte activation. Exp Cell Res 77:428–436
Kobayashi T, Okuma H, Azuma Y, Kiyoki M, Matsumoto K, Hashimoto K, Yoshikawa K (1990) 1α,24R-Dihydroxyvitamin D3 has an ability comparable to that of 1α,25-dihydroxyvitamin D3 to induce keratinocyte differentiation. J Dermatol 17:707–709
Kragballe K (1992) Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 49:46–52
Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243 (4897):1464–1466
Larsen CG, Kristensen M, Pauldan K, Deleuran B, Thomas MK, Zachariae C, Kragballe K, Matsushima K, Thestrup-Pedersen K (1991) 1,25(OH)2D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176(3):1020–1026
Marks F, Bertsch S, Furstenberger G (1979) Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo. Cancer Res 39:4183–4188
Marks F, Fürstenberger G, Kownatzki E (1981) Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 41:696–702
Matsumoto K, Hashimoto K, Kiyoki M, Yamamoto M, Yoshikawa K (1990) Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. J Dermatol 17:97–103
Matsunaga T, Yamamoto M, Mimura H, Ohta T, Kiyoki M, Ohba T, Naruchi T, Hosoi J, Kuroki T (1990) 1,24(R)-Dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J Dermatol 17:135–142
Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167(6):1883–1893
Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1α-hydroxyvitamin D3. Med J Osaka Univ 35:51
Murdoch D, Clissold SP (1992) Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 43(3):415–429
Nair S, Mayotte J, Lokshin A, Levitt M (1994) Induction of squamous differentiation by interferon β in a human non-small-cell lung cancer cell line. J Natl Cancer Inst 86(5):378–383
Nishimura M, Hori Y, Nishiyama S, Nakamizo Y (1993) Topical 1α,24(R)-dihydroxyvitamin D3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 3:255–261
O’Brien TG (1976) The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 36:2644–2653
O’Brien TG, Simsiman RC, Boutwell RK (1975) Induction of polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res 35:1662–1670
Ohta T, Takada Y, Mimura H, Yamamoto M, Matsunaga T, Kiyoki M, Ohba T, Naruchi T (1990) Pharmacokinetic studies of 1α,24(R)-(OH)2D3 (TV-02) (1): Plasma level, distribution metabolism and excretion after a single subcutaneous administraton to rats. Yakubutsu Doutai 5:3–24
Ohta T, Yamamoto M, Takada Y, Mimura H, Matsunaga T, Kiyoki M, Ohba T, Naruchi T (1990) Pharmacokinetic studies of 1α,24(R)-(OH)2D3 (TV-02) (3): Absorption, distribution and excretion after a single or continuous transcutaneous application to rats. Yakubutsu Doutai 5:39–52
Raick AN (1973) Ultrastructural histological and biochemical alterations produced by 12-O-tetradecanoylphorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res 33:269–286
Russell DH, Levy CC (1973) The roles of the polyamines, putrescine, spermidine, and spermine in normal and malignant tissues. Life Sci 13:1635–1647
Russell DH, McVicker TA (1971) Polyamine metabolism in mouse liver after partial hepatectomy. Biochim Biophys Acta 244:85–93
Russell DH, Snyder SH (1968) Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci USA 68:1420–1426
Russell DH, Combest WL, Duell EA, Stawiski M, Anderson TF, Voorhees JJ (1978) Glucocorticoid inhibits elevated polyamine biosynthesis in psoriasis. J Invest Dermatol 71:177–181
Smith EL, Walworth NC, Holick MF (1986) Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709–714
Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T (1982) 1α,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60): The presence of a cytosol receptor and induction of differentiation. Biochem J 204:713–719
Voorhees JJ (1983) Leukotrienes and other lipoxygenase products in pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 119:541–547
Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84(24):9233–9237
Yuspa SH, Ben T, Hennings H, Lichti U (1980) Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun 97:700–708
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, H., Sugimoto, I., Matsunaga, T. et al. Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice. Arch Dermatol Res 288, 656–663 (1996). https://doi.org/10.1007/BF02505274
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02505274